| Steven J Sondheimer, MD | |
|
3400 Spruce St, Philadelphia, PA 19104-4238 | |
| (215) 615-5234 | |
| (215) 349-5893 |
| Full Name | Steven J Sondheimer |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 50 Years |
| Location | 3400 Spruce St, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245265123 | NPI | - | NPPES |
| 000737036 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VE0102X | Obstetrics & Gynecology - Reproductive Endocrinology | MD016934E (Pennsylvania) | Secondary |
| 207V00000X | Obstetrics & Gynecology | MD016934E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Penn - Medical Group | 6204730955 | 3031 |
News Archive
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it is initiating a Phase 2 clinical study of STA-9090 in patients with advanced gastrointestinal stromal tumors (GIST). This is the sixth clinical study of STA-9090, a potent, synthetic, small molecule Hsp90 inhibitor with a novel chemical structure.
The March of Dimes and Stanford University School of Medicine today launched the nation's first transdisciplinary research center dedicated to identifying the causes of premature birth. Prematurity is the number one reason for newborn death in the United States today, yet in nearly half of the cases of premature birth, there is no identifiable cause.
Autism Spectrum Disorder is the fastest growing developmental disability in the United States, affecting 1 in 88 children, according to the CDC. As more families struggle to find answers and make sense of a diagnosis, National Autism Network announces the launch of an innovative, HIPAA-secure social network designed specifically and solely for the Autism community. This fully integrated social network offers features not currently found on any social network and was created to fill a void in the community.
Doctors increasingly are ditching the prescription pad. The latest count shows more than a third of the nation's prescriptions now are electronic... Surescripts, the largest network for paperless prescribing, found 390,000 doctors were e-prescribing at least some last year, and more are signing up fast. Some 36 percent of all prescriptions were electronic in 2011.
› Verified 7 days ago
| Entity Name | Lancaster General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720430812 PECOS PAC ID: 1254240039 Enrollment ID: O20040414000606 |
News Archive
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it is initiating a Phase 2 clinical study of STA-9090 in patients with advanced gastrointestinal stromal tumors (GIST). This is the sixth clinical study of STA-9090, a potent, synthetic, small molecule Hsp90 inhibitor with a novel chemical structure.
The March of Dimes and Stanford University School of Medicine today launched the nation's first transdisciplinary research center dedicated to identifying the causes of premature birth. Prematurity is the number one reason for newborn death in the United States today, yet in nearly half of the cases of premature birth, there is no identifiable cause.
Autism Spectrum Disorder is the fastest growing developmental disability in the United States, affecting 1 in 88 children, according to the CDC. As more families struggle to find answers and make sense of a diagnosis, National Autism Network announces the launch of an innovative, HIPAA-secure social network designed specifically and solely for the Autism community. This fully integrated social network offers features not currently found on any social network and was created to fill a void in the community.
Doctors increasingly are ditching the prescription pad. The latest count shows more than a third of the nation's prescriptions now are electronic... Surescripts, the largest network for paperless prescribing, found 390,000 doctors were e-prescribing at least some last year, and more are signing up fast. Some 36 percent of all prescriptions were electronic in 2011.
› Verified 7 days ago
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235527342 PECOS PAC ID: 6204730955 Enrollment ID: O20141111000091 |
News Archive
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it is initiating a Phase 2 clinical study of STA-9090 in patients with advanced gastrointestinal stromal tumors (GIST). This is the sixth clinical study of STA-9090, a potent, synthetic, small molecule Hsp90 inhibitor with a novel chemical structure.
The March of Dimes and Stanford University School of Medicine today launched the nation's first transdisciplinary research center dedicated to identifying the causes of premature birth. Prematurity is the number one reason for newborn death in the United States today, yet in nearly half of the cases of premature birth, there is no identifiable cause.
Autism Spectrum Disorder is the fastest growing developmental disability in the United States, affecting 1 in 88 children, according to the CDC. As more families struggle to find answers and make sense of a diagnosis, National Autism Network announces the launch of an innovative, HIPAA-secure social network designed specifically and solely for the Autism community. This fully integrated social network offers features not currently found on any social network and was created to fill a void in the community.
Doctors increasingly are ditching the prescription pad. The latest count shows more than a third of the nation's prescriptions now are electronic... Surescripts, the largest network for paperless prescribing, found 390,000 doctors were e-prescribing at least some last year, and more are signing up fast. Some 36 percent of all prescriptions were electronic in 2011.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven J Sondheimer, MD 3400 Spruce St, Philadelphia, PA 19104-4238 Ph: (215) 615-5234 | Steven J Sondheimer, MD 3400 Spruce St, Philadelphia, PA 19104-4238 Ph: (215) 615-5234 |
News Archive
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it is initiating a Phase 2 clinical study of STA-9090 in patients with advanced gastrointestinal stromal tumors (GIST). This is the sixth clinical study of STA-9090, a potent, synthetic, small molecule Hsp90 inhibitor with a novel chemical structure.
The March of Dimes and Stanford University School of Medicine today launched the nation's first transdisciplinary research center dedicated to identifying the causes of premature birth. Prematurity is the number one reason for newborn death in the United States today, yet in nearly half of the cases of premature birth, there is no identifiable cause.
Autism Spectrum Disorder is the fastest growing developmental disability in the United States, affecting 1 in 88 children, according to the CDC. As more families struggle to find answers and make sense of a diagnosis, National Autism Network announces the launch of an innovative, HIPAA-secure social network designed specifically and solely for the Autism community. This fully integrated social network offers features not currently found on any social network and was created to fill a void in the community.
Doctors increasingly are ditching the prescription pad. The latest count shows more than a third of the nation's prescriptions now are electronic... Surescripts, the largest network for paperless prescribing, found 390,000 doctors were e-prescribing at least some last year, and more are signing up fast. Some 36 percent of all prescriptions were electronic in 2011.
› Verified 7 days ago
Jennifer Bracken Imbriale, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3401 N Broad St Fl 7, Philadelphia, PA 19140 Phone: 215-707-3187 | |
Dr. Gabriela Isabel Gaudier-alemany, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5501 Old York Rd, Philadelphia, PA 19141 Phone: 215-456-8220 | |
Dr. Thomas A. Klein, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 834 Chestnut St, Suite 300, Philadelphia, PA 19107 Phone: 215-955-5000 Fax: 215-923-1089 | |
Abike T James, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, 5 Penn Tower, Philadelphia, PA 19104 Phone: 215-662-6035 | |
Mathew N Beshara, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3400 Spruce Street, 5 Penn Tower, Philadelphia, PA 19104 Phone: 215-662-6035 Fax: 215-349-5228 | |
Bernadette C Wheeler, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce Street, 1 West Gates, Philadelphia, PA 19104 Phone: 215-662-2730 Fax: 215-349-5224 | |
Deborah Schiller Schrager, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3998 Red Lion Rd, Suite 106, Philadelphia, PA 19114 Phone: 215-612-4143 Fax: 215-612-4909 |